168 related articles for article (PubMed ID: 8604715)
1. Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy.
Navarro JF; Quereda C; Quereda C; Gallego N; Antela A; Mora C; Ortuno J
Am J Kidney Dis; 1996 Mar; 27(3):431-4. PubMed ID: 8604715
[TBL] [Abstract][Full Text] [Related]
2. Nephrogenic diabetes insipidus associated with foscarnet--a case report.
Conn J; Colman P; Brown G; Street A; Bate K
J Antimicrob Chemother; 1996 Jun; 37(6):1179-81. PubMed ID: 8836823
[No Abstract] [Full Text] [Related]
3. Renal tubular acidosis following treatment with foscarnet.
Navarro JF; Quereda C; Moreno A; Quereda C
AIDS; 1995 Dec; 9(12):1389-90. PubMed ID: 8605068
[No Abstract] [Full Text] [Related]
4. Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis.
Farese RV; Schambelan M; Hollander H; Stringari S; Jacobson MA
Ann Intern Med; 1990 Jun; 112(12):955-6. PubMed ID: 2160217
[No Abstract] [Full Text] [Related]
5. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
6. CMV retinitis: a clinical management update.
Blanchet KD
AIDS Patient Care STDS; 1996 Apr; 10(2):86-93. PubMed ID: 11361712
[No Abstract] [Full Text] [Related]
7. Combined renal tubular acidosis and diabetes insipidus in hematological disease.
Hoorn EJ; Zietse R
Nat Clin Pract Nephrol; 2007 Mar; 3(3):171-5. PubMed ID: 17322929
[TBL] [Abstract][Full Text] [Related]
8. Foscarnet crystal deposition and renal failure.
Goldfarb DS; Coe FL
Am J Kidney Dis; 1998 Sep; 32(3):519-20. PubMed ID: 9740173
[No Abstract] [Full Text] [Related]
9. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Jabs DA
Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
[TBL] [Abstract][Full Text] [Related]
10. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of CMV retinitis with intravitreal foscarnet].
Cochereau I; Belayachi N; Diraison C; Matheron S; Bouyer I; Hoang-Xuan T; Saimot AG; Coulaud JP
J Fr Ophtalmol; 1998 Dec; 21(10):723-6. PubMed ID: 10052044
[TBL] [Abstract][Full Text] [Related]
12. Transient foscarnet-induced hypercalcaemia.
Barba R; Gómez-Rodrigo J; Marco J; Espejo M; Mena D
AIDS; 1998 Oct; 12(14):1930-1. PubMed ID: 9792397
[No Abstract] [Full Text] [Related]
13. High-dose intravitreal ganciclovir and foscarnet for cytomegalovirus retinitis.
Velez G; Roy CE; Whitcup SM; Chan CC; Robinson MR
Am J Ophthalmol; 2001 Mar; 131(3):396-7. PubMed ID: 11239885
[TBL] [Abstract][Full Text] [Related]
14. Convenient twice daily foscarnet in induction therapy of AIDS-associated cytomegalovirus retinitis. The Foscarnet Italian Study Group.
Carosi G; Castelli F; Lernestedt JO; Antoniazzi E; Gerna G
AIDS; 1997 Feb; 11(2):258-60. PubMed ID: 9030380
[No Abstract] [Full Text] [Related]
15. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
[No Abstract] [Full Text] [Related]
16. Comparison of pharmacokinetics and dynamics of two dosage regimens of foscarnet in AIDS patients with Cytomegalovirus retinitis.
Castelli F; Tomasoni L; Zeroli C; Suter F; Trespi G; Carosi G; Hedman A
Eur J Clin Pharmacol; 1997; 52(5):397-401. PubMed ID: 9272411
[TBL] [Abstract][Full Text] [Related]
17. Advances in treatment for cytomegalovirus retinitis.
Bowers M
BETA; 1995 Sep; ():13-5. PubMed ID: 11362885
[TBL] [Abstract][Full Text] [Related]
18. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
[TBL] [Abstract][Full Text] [Related]
19. Acquired nephrogenic diabetes insipidus secondary to distal renal tubular acidosis and nephrocalcinosis associated with Sjögren's syndrome.
Nagayama Y; Shigeno M; Nakagawa Y; Suganuma A; Takeshita A; Fujiyama K; Ashizawa K; Kiriyama T; Yokoyama N; Nagataki S
J Endocrinol Invest; 1994 Sep; 17(8):659-63. PubMed ID: 7868806
[TBL] [Abstract][Full Text] [Related]
20. A brighter future for the AIDS patient.
Lowell E; Van Tassell B
Insight; 2002; 27(4):95-6. PubMed ID: 12520982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
